Glenmark Seeks Rehearing Of $16M Tarka Patent Judgment
Glenmark Pharmaceuticals Ltd. urged the Federal Circuit on Wednesday to reconsider its decision to uphold a $16 million jury verdict that found the generic-drug maker had infringed a patent owned by...To view the full article, register now.
Already a subscriber? Click here to view full article